Rocket One Inc. Proceeds from Debt, Net of Issuance Costs
Rocket One Inc. (RKTO) reported Proceeds from Debt, Net of Issuance Costs of $1.01 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2023-03-31
- Rocket One Inc. proceeds from debt, net of issuance costs for the quarter ending 2022-12-31 was $0.00.
- Rocket One Inc. proceeds from debt, net of issuance costs for the quarter ending 2022-09-30 was $0.00.
- Rocket One Inc. proceeds from debt, net of issuance costs for the quarter ending 2022-06-30 was $1.01M.
- Rocket One Inc. proceeds from debt, net of issuance costs for the quarter ending 2022-03-31 was $0.00.
- Rocket One Inc. proceeds from debt, net of issuance costs for fiscal 2022 was $1.01M.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $1.01M derived: sum of 3 quarters · filed 2023-03-31 | $1.01M 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.01M derived: sum of 2 quarters · filed 2022-11-10 | $1.01M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.01M 10-Q · filed 2022-08-12 | $1.01M 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |